An analysis of drug resistance among people living with HIV/AIDS in Shanghai, China-Reference-Cited by-同舟云学术

An analysis of drug resistance among people living with HIV/AIDS in Shanghai, China

Published:2017-02-10 Issue:2 Volume:12 Page:e0165110
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zhang Fengdi,Liu Li,Sun Meiyan,Sun Jianjun,Lu Hongzhou

Funder

Natural Science Foundation of China

The National High Technology Research and Development Program (863 Program)

The fourth round of three-year public health active plan

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference31 articles.

1. The emergence of drug resistant HIV variants at virological failure of HAART combinations containing efavirenz, tenofovir and lamivudine or emtricitabine within the UK Collaborative HIV Cohort;N Bulteel;The Journal of infection,2014

2. Increasing HIV-1 pre-treatment drug resistance among antiretroviral-naive adults initiating treatment between 2006 and 2014 in Nairobi, Kenya;MH Chung;Aids,2016

3. Resistance development over 144 weeks in treatment-naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903;NA Margot;HIV medicine,2006

4. Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa;CJ Hoffmann;Clinical infectious diseases: an official publication of the Infectious Diseases Society of America,2009

5. High rate of HIV resuppression after viral failure on first-line antiretroviral therapy in the absence of switch to second-line therapy;RK Gupta;Clinical infectious diseases: an official publication of the Infectious Diseases Society of America,2014

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and transmission of pretreatment drug resistance in people living with HIV-1 in Shanghai China, 2017–2021;Virulence;2024-06-27

2. Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China;Journal of Antimicrobial Chemotherapy;2024-03-29

3. The profile of HIV-1 drug resistance in Shanghai, China: a retrospective study from 2017 to 2021;Journal of Antimicrobial Chemotherapy;2024-02-01

4. Retrospective Study on Genetic Diversity and Drug Resistance among People Living with HIV at an AIDS Clinic in Beijing;Pharmaceuticals;2024-01-16

5. Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended use;The Lancet HIV;2023-10